This may be too small a dataset to confidently draw any conclusions about these indications specifically; however, the results from the NSCLC small intra-block and intra-case study are supported by those from the much larger NSCLC dataset, giving confidence that our findings, particularly those relating to PD-L1 staining of TCs, can be applied across indications. This evidence concerns the gene CD274 and non-small cell lung carcinoma.